New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim

Neutropenia and febrile neutropenia are two major complications of chemotherapy. Dose reductions, delays in treatment administration, and the use of granulocyte colony-stimulating factors are equally recommended options to preserve absolute neutrophil count in case of chemotherapy regimens bringing...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Clin Risk Manag
Main Authors: Ghidini, Michele, Hahne, Jens Claus, Trevisani, Francesco, Panni, Stefano, Ratti, Margherita, Toppo, Laura, Tomasello, Gianluca
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4928625/
https://ncbi.nlm.nih.gov/pubmed/27445479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S80732
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados